Enanta Pharmaceuticals Inc (ENTA)

[DC15]

If no funding or co-marketing by $ENTA: $75M+ up-front cash; $250M+ regulatory milestones; $150M+ sales milestones; ~20% royalty on worldwide sales.

I too am hoping for more, although 2B in milestones/yr near term sounds pretty good, still the upfront is lower than I am hoping. I do not have the knowledge base to assess the current market value for this type of asset given the potential sales and potential losses if the drug does not make it to market. I am hoping for a buyout as I feel that ENANTA has demonstrated the creation of small molecule virus inhibitor development machine. Long ago I, and others too (from memory) were hoping for an 8B buyout price, that would be fine by me.

Let me know if my expectations are too high.